HIV-1 integration site preferences in pluripotent cells
Pluripotent Stem Cells
0301 basic medicine
Genomic Library
Virus Integration
Genetic Vectors
Genetic Therapy
Telomere
03 medical and health sciences
Cell Line, Tumor
HIV-1
Humans
Cloning, Molecular
DNA Primers
DOI:
10.2741/e260
Publication Date:
2010-11-28T18:56:35Z
AUTHORS (1)
ABSTRACT
HIV-1-based vectors are widely used in gene therapy. In somatic cells, these mainly integrate within genes. However, no distinct integration site preferences have been observed with regard to large chromosomal regions. The recent emergence of induced pluripotent stem (iPS) similar embryonic (ES) has raised questions about where occurs cells. this work we investigated the a pluripotent, ES-like cell line. We show that approximately 30% integrations occur vicinity telomeres. analyzed sites various as reported by us and other groups, pattern is unique conclude cells may contain cellular cofactors participate targeting not present
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....